In the Kaplan–Meier plotter bioinformatics analysis, higher expression of RAC1 and RRM2 were indicated to be an unfavorable prognostic factor for HER-2 positive breast cancer patients. This evidence concerns the gene ERBB2 and breast carcinoma.